Email Newsletters

MetroWest

Evergreen To Shutter Devens Facility

Marlborough-based Evergreen Solar will close its Devens manufacturing facility by the end of the first quarter of...

Genzyme, Sanofi Officially Talking

Genzyme Corp., the Cambridge-based biotechnology giant with significant operations in Central Massachusetts, acknowledged that it is in...

$4M For Alzheimer’s Testing Co.

Neuroptix Corp., an Acton company working on a test for the detection of Alzheimer's disease, has received...

Framingham Medical Co. Acquired

Interlace Medical Inc., a Framingham company that makes a system for removing uterine fibroids, has been acquired...
ADVERTISEMENT

Boston Office Market Grows

The Greater Boston office landscape continued to improve, though not rapidly, in the last quarter of 2010,...

BSX Buys Brain Stimulation Company

Natick-based medical device maker Boston Scientific Corp. has acquired Boston development-stage company Intelect Medical Inc. in a...

TJX December Sales Rise

Framingham-based discount retailer The TJX Cos Inc. saw a 6 percent increase in December sales this year,...

Southborough By The Numbers

Town Hall17 Common St., MA 01772508-485-0710www.southboroughtown.comStatsPopulation (2009): 9,724 Form of Government: Town administrator, selectmen, open town meetingLabor Force...
ADVERTISEMENT

BJ’s To Close Five Stores

Natick-based retailer BJ's Wholesale Club Inc. will close five stores by the end of the month. Three...

Qteros Gets $22M, Inks Partnership

Biofuel development company Qteros, which is headquartered in Marlborough, is getting $22 million in financing and has...
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

December Flash Sale! Get 40% off new subscriptions from now until December 19th!

Close the CTA

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA